Aprea Therapeutics, Inc. (APRE) — 分析师展望 / 分析师共识目标价为. 基于 8 位分析师评级, 共识为 看涨 — 4 买入, 2 持有, 2 卖出.
分析师预估 每股收益(EPS)为 $-2.51 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-2.35 vs 预期 $-2.51 (超预期 +6.4%). 2025: 实际 $-1.93 vs 预期 $-1.99 (超预期 +3%). 分析师准确度: 95%.
APRE 分析师评级
Buy
基于过去3个月内 8 位分析师对 Aprea Therapeutics, Inc. 的评级
EPS 预测 — APRE
95%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$2.35
vs Est –$2.51
▲ 6.8% off
2025
Actual –$1.93
vs Est –$1.99
▲ 3.1% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
营收预测 — APRE
93%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.002B
vs Est $0.001B
▲ 10.9% off
2025
Actual $0.000B
vs Est $0.000B
▼ 2.8% off
Revenue Trend
Revenue has declined over the period shown. Analysts expect stable revenue going forward.
